SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004054
Filing Date
2018-05-04
Accepted
2018-05-04 17:07:08
Documents
61
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q avxs-20180331x10q.htm 10-Q 873423
2 EX-10.1 avxs-20180331ex10140af41.htm EX-10.1 397142
3 EX-31.1 avxs-20180331ex311dd8000.htm EX-31.1 16438
4 EX-31.2 avxs-20180331ex31230292b.htm EX-31.2 16564
5 EX-32.1 avxs-20180331ex321f6deea.htm EX-32.1 9925
6 GRAPHIC avxs20180331ex10140af41001.jpg GRAPHIC 3336
7 GRAPHIC avxs20180331ex10140af41002.jpg GRAPHIC 7054
  Complete submission text file 0001558370-18-004054.txt   4334241

Data Files

Seq Description Document Type Size
8 EX-101.INS avxs-20180331.xml EX-101.INS 742158
9 EX-101.SCH avxs-20180331.xsd EX-101.SCH 35377
10 EX-101.CAL avxs-20180331_cal.xml EX-101.CAL 29716
11 EX-101.DEF avxs-20180331_def.xml EX-101.DEF 152402
12 EX-101.LAB avxs-20180331_lab.xml EX-101.LAB 328688
13 EX-101.PRE avxs-20180331_pre.xml EX-101.PRE 269730
Mailing Address 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015
Business Address 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015 972-725-7797
AveXis, Inc. (Filer) CIK: 0001652923 (see all company filings)

IRS No.: 901038273 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37693 | Film No.: 18808830
SIC: 2836 Biological Products, (No Diagnostic Substances)